CIK: 1834833 - Address: C/o Clovis Oncology, Inc., 5500 Flatiron Parkway, Suite 100, Boulder, CO 80301
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/3/22 16:15
11/2/22
CLVSClovis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsHarding Thomas C.COOSee RemaS.d-20.98290-2-723M
10/4/22 16:15
10/3/22
CLVSClovis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsHarding Thomas C.COOSee RemaS.d01.2900021I
9/6/22 16:15
9/2/22
CLVSClovis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsHarding Thomas C.COOSee RemaS.d-21.200-2-721M
8/3/22 16:15
8/2/22
CLVSClovis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsHarding Thomas C.COOSee RemaS.d-31.460-2-820M
7/6/22 16:15
7/5/22
CLVSClovis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsHarding Thomas C.COOSee RemaS.d02.7100018I
6/3/22 16:15
6/2/22
CLVSClovis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsHarding Thomas C.COOSee RemaS.d-10.64250-2-918M
5/3/22 16:15
5/2/22
CLVSClovis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsHarding Thomas C.COOSee RemaS.d-31.970-2-1016M
4/5/22 16:16
4/4/22
CLVSClovis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsHarding Thomas C.COOSee RemaS.d02.6600014I
3/3/22 16:15
3/2/22
CLVSClovis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsHarding Thomas C.COOSee RemaS.d-151.870-8-3514M
2/3/22 16:15
2/2/22
CLVSClovis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsHarding Thomas C.COOSee RemaS.d-41.940-2-208M

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact